Website intended for a NZ health professional readership
Sexual health specialist Massimo Giola looks at the evidence for doxycycline post-exposure prophylaxis as a prevention tool for syphilis, chlamydia and gonorrhoea
1. Highleyman L. Sexually transmitted infections in San Francisco have fallen since doxyPEP roll-out. 5 March 2024.
2. Centers for Disease Control and Prevention. Guidelines for the use of doxycycline post-exposure prophylaxis for bacterial sexually transmitted infection prevention. October 2023.
3. Cornelisse VJ, Ong JJ, Ryder N, et al. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand - the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Sex Health 2023;20(2):99–104.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
